scientifyRESEARCH
research funding database

RESEARCH FUNDING

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional | worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) funding from the National Institutes of Health (NIH) supports research at the intersection of HIV and aging by proposing research that aims to meet the following objectives:

  1. Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and
  2. Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Applications are open to researchers worldwide. The award provides up to 275,000 USD (plus indirect costs) for up to 2 years.

Funding opportunity number: PAR-24-092

The next applications close on September 7, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time